Cited by 175Sexual function and dysfunction studiesSchizophrenia research and treatmentTreatment of Major Depression

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Sexual side-effects of antidepressant and antipsychotic drugs

Montejo, Angel L., Montejo, Laura, Navarro-Cremades, Felipe·2015·Current Opinion in Psychiatry

Open this paper in CoChat — free account

Abstract

PURPOSE OF REVIEW: Psychotropic-related sexual dysfunction is a quite frequent issue in clinical practice, mainly in chronic treatments affecting both quality of life and compliance. RECENT FINDINGS: In the last decade fortunately antidepressants and antipsychotic compounds have been deeply screened in order to identify sexual adverse events that were commonly underdiagnosed and previously underestimated by clinicians and perhaps by pharmaceutical companies as well. Some differences in the mechanism of action are the nucleus of this poorly tolerated adverse event. All antidepressants with serotonergic activity can cause mild to severe sexual dysfunction such as decreased libido and delayed orgasm frequently (>60%) or anorgasmia and arousal difficulties sometimes (30%). In contrast, noradrenergic, dopaminergic, or melatonergic antidepressants do not cause sexual dysfunction but perhaps the clinical profile of patients receiving these compounds could be different. Antipsychotics that highly increase prolactin levels and strongly block dopamine receptors could be related to sexual dysfunction as well. Unfortunately, these dysfunctions are present during the long term after the antipsychotic onset to provide continued symptom control and enable recovery. Young patients suffering psychosis and concomitant sexual dysfunction (erectile and/or orgasmic difficulties) tend to show poor compliance in chronic treatments affecting the outcomes. SUMMARY: The implications of psychotropic-related sexual dysfunction in clinical practice are relevant mainly in patients under long-term treatment with previous satisfactory sexual life. Implications for future research about sexual dysfunction in all new treatments should be strongly taken into account.

Integrity signals

Registry

Crossref · 10.1097/yco.0000000000000198

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Effects of SSRIs on Sexual Function
Rosen, R. C., Lane, R. M., & Menza, M. A. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00013 · Cited by 654
Treatment-Emergent Sexual Dysfunction Related to Antidepressants: A Meta-Analysis
Serretti, A., & Chiesa, A. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a5233f · Cited by 583
Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients
Montejo-gonzàlez, A. L., Llorca, G., Izquierdo, J. A., Ledesma, A., Bousono, M., Calcedo, A., Carrasco, J. L., Ciudad, J., Daniel, E., De LA Gandara, J., et al. (1997) · Journal of Sex & Marital Therapy · doi:10.1080/00926239708403923 · Cited by 505
Self-citation
Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
Taylor, D. M., Sparshatt, A., Varma, S., & Olofinjana, O. (2014) · BMJ · doi:10.1136/bmj.g1888 · Cited by 343
A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics
Serretti, A., & Chiesa, A. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328341e434 · Cited by 208
The Facts About Sexual (Dys)function in Schizophrenia: An Overview of Clinically Relevant Findings
de Boer, M. K., Castelein, S., Wiersma, D., Schoevers, R. A., & Knegtering, H. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv001 · Cited by 173
Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis
Reichenpfader, U., Gartlehner, G., Morgan, L. C., Greenblatt, A., Nussbaumer, B., Hansen, R. A., Van Noord, M., Lux, L., & Gaynes, B. N. (2014) · Drug Safety · doi:10.1007/s40264-013-0129-4 · Cited by 160
Antidepressants and Sexual Dysfunction: Mechanisms and Clinical Implications
Clayton, A. H., Croft, H. A., & Handiwala, L. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.03.2744 · Cited by 157
The role of oxytocin in male and female reproductive behavior
Veening, J. G., A, T. R. D. J., Waldinger, M. D., Korte, S. M., & Olivier, B. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.045 · Cited by 156
Changes in Sexual Functioning Associated with Duloxetine, Escitalopram, and Placebo in the Treatment of Patients with Major Depressive Disorder
Clayton, A. H., Kornstein, S. G., Prakash, A., Mallinckrodt, C. H., & Wohlreich, M. M. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00520.x · Cited by 152
Frequency of Sexual Dysfunction in Patients with a Psychotic Disorder Receiving Antipsychotics
Montejo, A. L., for the Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction, Majadas, S., Rico‐Villademoros, F., Llorca, G., de la Gándara, J., Franco, M., Martı́n-Carrasco, M., Aguera, L., & Prieto, N. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01709.x · Cited by 132
Self-citation
Saffron for treatment of fluoxetine‐induced sexual dysfunction in women: randomized double‐blind placebo‐controlled study
Kashani, L., Raisi, F., Saroukhani, S., Sohrabi, H. R., Modabbernia, A., Nasehi, A.-A., Jamshidi, A. H., Ashrafi, M., Mansouri, P., Ghaeli, P., et al. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2282 · Cited by 125
Psychiatric disorders and sexual dysfunction
Waldinger, M. D. (2015) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63247-0.00027-4 · Cited by 117
Erratum: Agomelatine, the first melatonergic antidepressant: discovery, characterization and development
de Bodinat, C., Lemaître, B. J., Mocaër, E., Renard, P., Muñoz, C., & Millan, M. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3274 · Cited by 107
Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale
Montejo, A. L., Prieto, N., Terleira, A. I., Matias, J., Alonso, S., Paniagua, G., Naval, S., Parra, D., Gabriel, C., Mocaër, E., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108096507 · Cited by 99
Self-citation
Hyperprolactinémies induites par les antipsychotiques : physiopathologie, clinique et surveillance
Besnard, I., Auclair, V., Callery, G., Gabriel-Bordenave, C., & Roberge, C. (2013) · L Encéphale · doi:10.1016/j.encep.2012.03.002 · Cited by 95
Sexual Function during Bupropion or Paroxetine Treatment of Major Depressive Disorder
Kennedy, S. H., Fulton, K., Bagby, R. M., Greene, A. L., Cohen, N. L., & Rafi‐Tari, S. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100405 · Cited by 94
Psychometric Properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in Patients with Schizophrenia and Other Psychotic Disorders
Montejo, A. L., & Rico‐Villademoros, F. (2008) · Journal of Sex & Marital Therapy · doi:10.1080/00926230701866125 · Cited by 90
Self-citation
Antidepressant-induced sexual dysfunction in men
Segraves, R. T., & Balon, R. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.003 · Cited by 89
Sexual Dysfunction Related to Psychotropic Drugs: A Critical Review - Part I: Antidepressants
Torre, A. L., Giupponi, G., Duffy, D. M., & Conca, A. (2013) · Pharmacopsychiatry · doi:10.1055/s-0033-1345205 · Cited by 85
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Vortioxetine in Adults With Major Depressive Disorder
Mahableshwarkar, A. R., Jacobsen, P. L., Serenko, M., Chen, Y., & Trivedi, M. H. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09337 · Cited by 84
Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
Alvarez, E., Artigas, F., & Perez, V. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s41387 · Cited by 84
Neural Correlates of Antidepressant-Related Sexual Dysfunction: A Placebo-Controlled fMRI Study on Healthy Males Under Subchronic Paroxetine and Bupropion
Abler, B., Seeringer, A., Hartmann, A., Grön, G., Metzger, C. D., Walter, M., & Stingl, J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.66 · Cited by 84
Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder
Alam, M. Y., Jacobsen, P. L., Chen, Y., Serenko, M., & Mahableshwarkar, A. R. (2013) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000010 · Cited by 76
Antidepressant drugs and sexual dysfunction
Baldwin, D. S., & Foong, T. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.110650 · Cited by 73
Testosterone Improves Antidepressant-Emergent Loss of Libido in Women: Findings from a Randomized, Double-Blind, Placebo-Controlled Trial
Fooladi, E., Bell, R. J., Jane, F., Robinson, P. J., Kulkarni, J., & Davis, S. R. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12426 · Cited by 60
Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review
Binder, M. D., Detraux, J., & Peuskens, J. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.906579 · Cited by 51
Vortioxetine: A Review of Its Use in Major Depressive Disorder
Garnock-Jones, K. P. (2014) · CNS Drugs · doi:10.1007/s40263-014-0195-x · Cited by 49
A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine
Deardorff, W. J., & Grossberg, G. T. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.960842 · Cited by 49
Desvenlafaxine 50 and 100 mg/d Versus Placebo for the Treatment of Major Depressive Disorder
Clayton, A. H., Tourian, K. A., Focht, K., Hwang, E., Cheng, R.-F. J., & Thase, M. E. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08978 · Cited by 41
Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo
Clayton, A. H., Gommoll, C., Chen, D., Núñez, R., & Mathews, M. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000075 · Cited by 38
Resolution of sexual dysfunction during acute treatment of major depression with milnacipran
Baldwin, D. S., Moreno, R. A., & Briley, M. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.955 · Cited by 34
Management of antidepressant-induced sexual dysfunction
Keks, N. A., Hope, J., & Culhane, C. (2014) · Australasian Psychiatry · doi:10.1177/1039856214556323 · Cited by 34
Efficacy of Acupuncture Treatment of Sexual Dysfunction Secondary to Antidepressants
Khamba, B., Aucoin, M., Lytle, M., Vermani, M., Maldonado, A., Iorio, C., Cameron, C., Tsirgielis, D., D’Ambrosio, C., Anand, L., et al. (2013) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2012.0751 · Cited by 33
A Systematic Review of Instruments to Measure Sexual Functioning in Patients Using Antipsychotics
de Boer, M. K., Castelein, S., Wiersma, D., Schoevers, R. A., & Knegtering, H. (2014) · The Journal of Sex Research · doi:10.1080/00224499.2013.865111 · Cited by 31
An Evaluation of Sexual Functioning in Employed Outpatients with Major Depressive Disorder Treated with Desvenlafaxine 50mg or Placebo
Clayton, A. H., Reddy, S., Focht, K., Musgnung, J. J., & Fayyad, R. S. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02899.x · Cited by 30
The Antipsychotics and Sexual Functioning Questionnaire (ASFQ): Preliminary evidence for reliability and validity
de Boer, M. K., Castelein, S., Bous, J., van den Heuvel, E. R., Wiersma, D., Schoevers, R. A., & Knegtering, H. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.08.037 · Cited by 30
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study
Clayton, A. H., Baker, R. A., Sheehan, J. J., Cain, Z., Forbes, R. A., Marler, S. V., Marcus, R. N., Berman, R., & Thase, M. E. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-459 · Cited by 26
Talking About Sexuality With Consumers of Mental Health Services
Quinn, C., & Happell, B. (2012) · Perspectives In Psychiatric Care · doi:10.1111/j.1744-6163.2012.00334.x · Cited by 26
Regulatory and Scientific Issues in Studies to Evaluate Sexual Dysfunction in Antidepressant Drug Trials
Khin, N. A., Kronstein, P. D., Yang, P., Ishida, E., Hung, H., Mathis, M. V., Unger, E. F., & Temple, R. J. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14cs09700 · Cited by 23
Reports of Sexual Disorders Related to Serotonin Reuptake Inhibitors in the French Pharmacovigilance Database: An Example of Underreporting
Trenque, T. C., Maura, G., Herlem, E., Vallet, C., Solé, E., Auriche, P., & Dramé, M. (2013) · Drug Safety · doi:10.1007/s40264-013-0069-z · Cited by 13
The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysis
Druyts, E., Eapen, S., Wu, P., & Thorlund, K. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-116 · Cited by 9
Improvement of Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction Without Worsening of Depressive Symptom After Switching to Milnacipran
Takahashi, H., & Ishigooka, J. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181906752 · Cited by 4

Research works printed but not linked: 10

Clayton, 2006, J Clin Psychiatry, 67, 33
Bijlsma, 2014, Behav, 121, 88
Montejo, 2001, J Clin Psychiatry, 62, 10
Montejo, 2000, Actas Esp Psiquiatr, 28, 141
Citrome, 2012, Pract, 66, 356
Dording, 2015, Evid Based Compl Altern Med, 2015, 949036
Baldwin, 2013, Depress Res Treat, 2013, 256841
Clayton, 1997, Psychopharmacol Bull, 33, 731
Montejo, 2014, Eur Psychiatry, 29, 1
Meng, 25, Erratum in: Shanghai Arch Psychiatry 2 Apr, 27, 89

Sorted by citations

Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, E., Radix, A., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M. G., Green, J., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2100644 · Cited by 3,022
The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
Solmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., Stubbs, B., Monaco, F., Vieta, E., Seeman, M., et al. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s117321 · Cited by 438
Antidepressant‐induced sexual dysfunction
Rothmore, J. (2020) · Medical Journal of Australia · doi:10.5694/mja2.50522 · Cited by 229
Neuroanatomy and function of human sexual behavior: A neglected or unknown issue?
Calabrò, R. S., Cacciola, A., Bruschetta, D., Milardi, D., Quattrini, F., Sciarrone, F., Rosa, G. L., Bramanti, P., & Anastasi, G. (2019) · Brain and Behavior · doi:10.1002/brb3.1389 · Cited by 228

See all 175

Authors: Montejo, A. L., Montejo, L., & Navarro-Cremades, F.
Affiliations: Universidad de Salamanca (ES)
Universitat de Miguel Hernández d'Elx (ES)
Corresponding author: Montejo, Angel L.
Montejo, Laura
ORCID: Montejo, Angel L.
Montejo, Laura
Navarro-Cremades, Felipe
Venue: Current Opinion in Psychiatry
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2015-11
Volume: 28
Issue: 6
Pages: 418-423
ISSN: 0951-7367 (ISSN-L)
DOI: 10.1097/yco.0000000000000198
OpenAlex: W2400902966
Cited by: 175
References: 43
Citations by year: 2026: 8 · 2025: 16 · 2024: 10 · 2023: 23 · 2022: 25 · 2021: 22 · 2020: 13 · 2019: 21 · 2018: 15 · 2017: 13 · 2016: 8 · 2015: 1
FWCI: 1.70
Type: journal article
Language: en
Open access: closed
Locations: Current Opinion in Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords: sexual dysfunction, antidepressants, antipsychotic drugs, low libido, anorgasmia, prolactin, dopamine receptor blockade, serotonergic antidepressants, noradrenergic antidepressants, melatonergic antidepressants, medication adherence
MeSH terms: Antidepressive Agents, Female, Humans, Erectile Dysfunction, Libido, Male, Orgasm, Psychotic Disorders, Psychotropic Drugs, Quality of Life, Receptors, Dopamine, Receptors, Serotonin, Sexual Behavior, Antipsychotic Agents, Sexual Dysfunctions, Psychological, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Sexual side-effects of antidepressant and antipsychotic drugs

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks